DK1173439T3 - Halogenalkoxy-imidazonaphthyridiner - Google Patents

Halogenalkoxy-imidazonaphthyridiner

Info

Publication number
DK1173439T3
DK1173439T3 DK00918882T DK00918882T DK1173439T3 DK 1173439 T3 DK1173439 T3 DK 1173439T3 DK 00918882 T DK00918882 T DK 00918882T DK 00918882 T DK00918882 T DK 00918882T DK 1173439 T3 DK1173439 T3 DK 1173439T3
Authority
DK
Denmark
Prior art keywords
imidazonaphthyridiner
haloalkoxy
compounds
useful
preventing
Prior art date
Application number
DK00918882T
Other languages
Danish (da)
English (en)
Inventor
Gerhard Grundler
Wolfgang-Alexander Simon
Stefan Postius
Wolfgang Kromer
Joerg Senn-Bilfinger
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of DK1173439T3 publication Critical patent/DK1173439T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Electroluminescent Light Sources (AREA)
DK00918882T 1999-04-17 2000-04-14 Halogenalkoxy-imidazonaphthyridiner DK1173439T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99107688 1999-04-17
PCT/EP2000/003388 WO2000063211A1 (en) 1999-04-17 2000-04-14 Haloalkoxy imidazonaphthyridines

Publications (1)

Publication Number Publication Date
DK1173439T3 true DK1173439T3 (da) 2003-09-08

Family

ID=8237986

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00918882T DK1173439T3 (da) 1999-04-17 2000-04-14 Halogenalkoxy-imidazonaphthyridiner

Country Status (12)

Country Link
US (1) US6503923B1 (ja)
EP (1) EP1173439B1 (ja)
JP (1) JP2002542248A (ja)
AT (1) ATE240956T1 (ja)
AU (1) AU3966600A (ja)
CA (1) CA2370231A1 (ja)
DE (1) DE60002855T2 (ja)
DK (1) DK1173439T3 (ja)
ES (1) ES2199810T3 (ja)
PT (1) PT1173439E (ja)
SI (1) SI1173439T1 (ja)
WO (1) WO2000063211A1 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2426616A1 (en) 2000-10-25 2002-05-02 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
IL157461A0 (en) * 2001-03-08 2004-03-28 Astrazeneca Ab Astrazeneca Ab Use of carboxamido imidazo [1,2] pyridine deivatives in the preparation of medicaments for treating or preventing gastric ulcer
US6927292B2 (en) 2001-08-02 2005-08-09 Altana Pharma Ag Tricyclic epoxides
WO2003014120A1 (en) * 2001-08-03 2003-02-20 Altana Pharma Ag Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
KR20040023697A (ko) * 2001-08-03 2004-03-18 알타나 파마 아게 위장관계 장애의 치료를 위한 알킬 치환 이미다조피리딘
JP2005519933A (ja) 2002-02-15 2005-07-07 アルタナ　ファルマ　アクチエンゲゼルシャフト 三環式ｎ−アシル化合物
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
CN100384842C (zh) 2002-11-19 2008-04-30 奥坦纳医药公司 8-取代的咪唑并吡啶类化合物
WO2004071391A2 (en) * 2003-02-17 2004-08-26 Altana Pharma Ag Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders
EP1606261B1 (en) 2003-03-10 2009-11-04 Nycomed GmbH Novel process for the preparation of roflumilast
WO2004105795A1 (en) * 2003-05-27 2004-12-09 Altana Pharma Ag Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2－a]吡啶衍生物
AR046893A1 (es) * 2003-12-16 2005-12-28 Altana Pharma Ag Bencimidazoles triciclicos
WO2005058894A1 (en) 2003-12-19 2005-06-30 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
AR047605A1 (es) * 2004-02-17 2006-01-25 Altana Pharma Ag Imidazopiridinas triciclicas e intermediarios en la sintesis de las mismas,sus procesos de preparacion,composiciones farmaceuticas que los contienen y usos.
US8366735B2 (en) * 2004-09-10 2013-02-05 Penumbra, Inc. System and method for treating ischemic stroke
CA2582256A1 (en) * 2004-10-01 2006-04-13 Altana Pharma Ag Substituted tricyclic benzimidazoles
EP1861074B1 (en) * 2005-03-16 2013-04-24 Takeda GmbH Taste masked dosage form containing roflumilast

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
IL108520A (en) 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HUP0001555A3 (en) 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
PL193616B1 (pl) 1998-09-23 2007-02-28 Altana Pharma Ag Tetrahydropirydoetery

Also Published As

Publication number Publication date
JP2002542248A (ja) 2002-12-10
US6503923B1 (en) 2003-01-07
CA2370231A1 (en) 2000-10-26
DE60002855D1 (de) 2003-06-26
SI1173439T1 (en) 2003-10-31
EP1173439B1 (en) 2003-05-21
ES2199810T3 (es) 2004-03-01
WO2000063211A1 (en) 2000-10-26
PT1173439E (pt) 2003-10-31
AU3966600A (en) 2000-11-02
DE60002855T2 (de) 2004-05-06
EP1173439A1 (en) 2002-01-23
ATE240956T1 (de) 2003-06-15

Similar Documents

Publication Publication Date Title
ATE240956T1 (de) Haloalkoxy-imidazonaphthyridine
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
ATE527250T1 (de) 2,4,6-trisubstituierten pyrimidinen als phosphotidylinositol (pi) 3-kinase inhibitoren und deren verwendung zur behandlung von krebs
BR9916798A (pt) 4-arilamino, 4-arilóxi e 4-ariltio diarilaminas e seus derivados como inibidores seletivos de mek
TR200002617T2 (tr) Aril ve heteroaril sübstitüentli heterosiklik üreler kullanılarak RAF kinazın inhibe edilmesi
NZ516562A (en) Pyrimidine-2,4,6-trione metalloproteinase inhibitors
DE60121461D1 (de) Kondensierte pyridoindolderivate
PT1325011E (pt) Metodos e compostos para tratamento de doencas proliferativas
ATE332302T1 (de) Alkylierte imidazopyridinderivate
MY121046A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
ATE391715T1 (de) Heterozyklische mutilinester und deren verwendung als bakterizide
ATE389655T1 (de) Pyrimidinderivate
DK1268472T3 (da) 3-aminopyrazolinhibitorer af cyclinafhængige kinaser
DE60112960D1 (de) Kondensierte pyridoindolderivate
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
MXPA04005129A (es) Uso de diamina de acido piridin-2,4-dicarboxilico y de diaminas de acido pirimidin-4,6-dicarboxilico para la inhibicion selectiva de la colagenasa.
MY135375A (en) Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
ATE259813T1 (de) Triazolopyrimidinderivate
DE60315288D1 (de) Cyanoguanidin prodrugs
PT1000046E (pt) Derivados de piperazina activos no trato urinario inferior
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
DK1244643T3 (da) Tryptaseinhibitorer
TR200103858T2 (tr) Hücre yapışmasının önleyicileri olarak ikame edilmiş purin türevleri